McCormick & Co. Inc. Stock Rises Monday, Outperforms Market

Tharimmune Inc

Change company Symbol lookup

Select an option...

THAR Tharimmune Inc

FATH Fathom Digital Manufacturing Corp

PAYX Paychex Inc

WAVD Wavedancer Inc

RNXT RenovoRx Inc

GBNY Generations Bancorp NY Inc

POL Polished.Com Inc

MDGS Medigus Ltd

GTH Genetron Holdings Ltd

NIO NIO Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |

Company profile

Tharimmune, Inc., formerly Hillstream BioPharma, Inc., is a pre-clinical biotechnology company. The Company is engaged in developing therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for treatment-resistant cancers. The Company’s lead product candidate is HSB-1216, an IMCD modulator, targeting a variety of solid tumors. The drug HSB-1216 was found to reduce tumor in burden treatment resistant cancers, including triple negative breast cancer and epithelial carcinomas. The Company uses Quatramer, a tumor targeting platform, to enhance the uptake of HSB-1216 in the tumor microenvironment (TME). Its Trident Artificial Intelligence, an artificial intelligence precision medicine platform used to identify biomarkers in clinical programs to target specific patient segments. The Company's pipeline includes HSB-1216, HSB-888, HSB-510 and HSB-114. HSB-1216 pipeline is a novel inducer of iron-mediated cell death.

McCormick & Co. Inc. Stock Rises Monday, Outperforms Market

5:11 pm ET May 15, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of McCormick & Co. Inc. (MKC) inched 0.63% higher to $90.85 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.30% to 4,136.28 and the Dow Jones Industrial Average rising 0.14% to 33,348.60.

This was the stock's fifth consecutive day of gains.

McCormick & Co. Inc. closed $10.55 short of its 52-week high ($101.40), which the company achieved on May 16th.

Trading volume (1.4 M) remained 85,813 below its 50-day average volume of 1.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

May 15, 2023 17:11 ET (21:11 GMT)